MIST - Milestone Pharmaceuticals cuts salaries to reduce expenses June, 09 2020 09:36 AM Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals (NASDAQ:MIST) +13% has instituted temporary salary reductions in connection with its plan to reduce OpEx.More news on: Milestone Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, Read more ...